DIFFERENTIAL EFFECT OF SODIUM-IONS AND GUANINE-NUCLEOTIDES ON THE BINDING OF THIOPERAMIDE AND CLOBENPROPIT TO HISTAMINE H-3 RECEPTORS IN RAT CEREBRAL CORTICAL MEMBRANES

被引:41
作者
CLARK, EA [1 ]
HILL, SJ [1 ]
机构
[1] QUEENS MED CTR,SCH MED,DEPT PHYSIOL & PHARMACOL,NOTTINGHAM NG7 2UH,ENGLAND
关键词
HISTAMINE H-3 RECEPTORS; H-3] N-ALPHA-METHYLHISTAMINE; SODIUM IONS; GUANYLNUCLEOTIDES;
D O I
10.1111/j.1476-5381.1995.tb13234.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 Conflicting reports in the literature over heterogeneity (West et al., 1990) or homogeneity (Arrang et al., 1990) of histamine H-3-receptor binding sites may be attributed to the use of different incubation conditions. In the present study we have investigated the extent to which the binding of H-3-receptor ligands to rat cerebral cortical membranes can be modified by both sodium ions and guanine nucleotides. 2 The H-3-selective antagonist, thioperamide, discriminated between two specific binding sites for [H-3]-N-alpha-methylhistamine (IC50 1 = 2.75 +/- 0.87 nM, IC50 2 = 101.6 +/- 12.0 nM, % site 1 = 24 +/- 2%) in 50 mM Tris HCl buffer, but showed homogeneity of binding in 50 mM Na/K phosphate buffer. 3 Sodium ions markedly altered the binding characteristics of thioperamide (i.e. heterogeneity was lost and IC50 value shifted towards the high affinity site). The competition curves for a second H-3-antagonist, clobenpropit and the H-3-agonist N-alpha-methylhistamine however, were unaltered in the presence of sodium ions. 4 Guanylnucleotides displaced only 60% of specific [H-3]-N-alpha-methylhistamine binding and modulated thioperamide binding in the same way as sodium ions. 5 These data suggest that the H-3-receptor can exist in different conformations for which thioperamide, but not N-alpha-methylhistamine and clobenpropit, show differential affinity. 6 The potential nature of these sites, and the implications of this apparent receptor heterogeneity for H-3-receptor antagonism by thioperamide, are discussed.
引用
收藏
页码:357 / 362
页数:6
相关论文
共 29 条
[1]   AUTO-INHIBITION OF BRAIN HISTAMINE-RELEASE MEDIATED BY A NOVEL CLASS (H-3) OF HISTAMINE-RECEPTOR [J].
ARRANG, JM ;
GARBARG, M ;
SCHWARTZ, JC .
NATURE, 1983, 302 (5911) :832-837
[2]   AUTO-REGULATION OF HISTAMINE-RELEASE IN BRAIN BY PRESYNAPTIC H-3-RECEPTORS [J].
ARRANG, JM ;
GARBARG, M ;
SCHWARTZ, JC .
NEUROSCIENCE, 1985, 15 (02) :553-562
[3]   HISTAMINE H-3 RECEPTOR-BINDING SITES IN RAT-BRAIN MEMBRANES - MODULATIONS BY GUANINE-NUCLEOTIDES AND DIVALENT-CATIONS [J].
ARRANG, JM ;
ROY, J ;
MORGAT, JL ;
SCHUNACK, W ;
SCHWARTZ, JC .
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1990, 188 (4-5) :219-227
[4]   AUTOINHIBITION OF HISTAMINE SYNTHESIS MEDIATED BY PRESYNAPTIC H-3 RECEPTORS [J].
ARRANG, JM ;
GARBARG, M ;
SCHWARTZ, JC .
NEUROSCIENCE, 1987, 23 (01) :149-157
[5]   HIGHLY POTENT AND SELECTIVE LIGANDS FOR HISTAMINE RECEPTORS-H-3 [J].
ARRANG, JM ;
GARBARG, M ;
LANCELOT, JC ;
LECOMTE, JM ;
POLLARD, H ;
ROBBA, M ;
SCHUNACK, W ;
SCHWARTZ, JC .
NATURE, 1987, 327 (6118) :117-123
[6]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[7]  
BURNS RF, 1983, ANAL BIOCHEM, V132, P74
[8]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[9]  
CHIDIAC P, 1993, MOL PHARMACOL, V45, P490
[10]  
CLAPHAM J, 1992, BRIT J PHARMACOL, V109, P919